Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 21, 2021 - Issue 2
Submit an article Journal homepage
3,390
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study

Marina Talamontia Dermatology Department, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-3070-4071
ORCID Icon,
Marco Galluzzoa Dermatology Department, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3424-5175
ORCID Icon,
Andrea Chiricozzib Fondazione Policlinico Universitario A. Gemelli IRCCS, Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Rome, Italy;c Università Cattolica del Sacro Cuore, Dermatologia, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-6739-0387
ORCID Icon,
Pietro Quaglinod Medical Sciences Department, Dermatologic Clinic, University of Turin, Turin, Italy
,
Gabriella Fabbrocinie Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
,
Paolo Gisondif Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
,
Angelo Valerio Marzanog Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;h Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy
,
Concetta Potenzai Department of Medico-Surgical Sciences and Biotechnologies, Dermatology Unit “Daniele Innocenzi” Sapienza University of Rome - Polo Pontino, Rome, Italy
,
Andrea Contij Dermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy
,
Aurora Parodik Clinica Dermatologica DiSSal Università di Genova, Ospedale-Policlinico San Martino IRCCS Genova, Italy
,
Stefano Piasericol Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy
,
Federico Bardazzim Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
,
Giuseppe Argenzianon Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy
,
Franco Rongiolettio Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
,
Luca Stingenip Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy
,
Giuseppe Micaliq Dermatology Clinic, University of Catania, Catania, Italy
,
Francesco Loconsoler Department of Biomedical Science and Human Oncology, Unit of Dermatology, University of Bari, Bari, Italy
,
Maria Teresa Rossis Department of Dermatology, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy
,
Maria Rita Bongiornot Section of Dermatology, Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization, University of Palermo, Palermo, Italy
,
Claudio Felicianiu Department of Medicine and Surgery, Section of Dermatology, University of Parma, Parma, Italy
,
Pietro Rubegniv Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Siena, Italy
,
Paolo Ameriow Department of Medicine and Aging Science, Dermatologic Clinic, G. D’Annunzio University, Chieti, Italy
,
Maria Concetta Fargnolix Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
,
Paolo Pigattoy Department of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan, Milan, Italy
,
Paola Savoiaz Department of Health Science, Dermatologic Clinic, University of Eastern Piedmont, Novara, Italy
,
Steven Paul Nisticòaa Dermatology Unit, Department of Health Sciences, Università Magna Graecia, Catanzaro, Italy
,
Sandra Giustinibb Department of Dermatology, ‘Sapienza’ University of Rome, Rome, Italy
,
Andrea Carugnocc Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalyORCID Iconhttps://orcid.org/0000-0002-8231-2205
ORCID Icon,
Serafinella Patrizia Cannavo’dd Dermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
,
Giulia Rechee Division of Dermatology, Santa Chiara Hospital, Trento, Italy
,
Francesca Prignanoff Dermatology Clinic, Department of Health Sciences, University of Florence, Florence, Italy
,
Annamaria Offidanigg Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy
,
Maurizio Lombardohh Unit of Dermatological Diseases, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy
,
Iris Zalaudekii Department of Dermatology, University of Trieste, Trieste, Italy
,
Luca Bianchia Dermatology Department, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-8697-6896
ORCID Icon,
Ketty Perisb Fondazione Policlinico Universitario A. Gemelli IRCCS, Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Rome, Italy;c Università Cattolica del Sacro Cuore, Dermatologia, Rome, Italy
& for the PSO-BIO-COVID study group show all
Pages 271-277 | Received 06 Oct 2020, Accepted 17 Nov 2020, Published online: 13 Jan 2021

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Kevin V. Kwee, Jean-Luc Murk, Qiqi Yin, M. Birgitte Visch, Linda Davidson, Elke M. G. J. de Jong, Juul M. P. A. van den Reek & Milan Tjioe. (2023) Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID). Journal of Dermatological Treatment 34:1.
Read now
Paolo Gisondi, Davide Geat, Francesco Bellinato & Giampiero Girolomoni. (2022) Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis. Expert Opinion on Biological Therapy 22:12, pages 1521-1529.
Read now
Jiajing Lu & Yuling Shi. (2022) A review of disease burden and clinical management for generalized pustular psoriasis in China. Expert Review of Clinical Immunology 18:10, pages 1023-1032.
Read now
Selda Pelin Kartal, Gökçen Çelik, Oğuz Yılmaz, Eda Öksüm Solak, Büşra Demirbağ Gül, Tuba Kevser Üstünbaş, Melis Gönülal, Sevim Baysak, Esma İnan Yüksel, Begüm Ünlü, Münevver Güven, Ali Bozdağ, Gökhan Çınar, Selim Kartal, Murat Borlu, Müge Güler Özden, Burhan Engin, Server Serdaroğlu, Didem Didar Balcı, Bilal Doğan, Demet Çiçek, Ayça Cordan Yazıcı, Sema Aytekin, Neslihan Şendur, Hayriye Sarıcaoglu, Nida Gelincik Kaçar, Asena Cigdem Doğramacı, Levent Dönmez & Erkan Alpsoy. (2022) The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey. Journal of Dermatological Treatment 33:4, pages 2137-2144.
Read now
Clara De Simone, Maria Concetta Fargnoli, Paolo Amerio, Luca Bianchi, Maria Esposito, Federico Pirro, Concetta Potenza, Federica Ricceri, Franco Rongioletti, Luca Stingeni & Francesca Prignano. (2021) Risk of infections in psoriasis: assessment and challenges in daily management. Expert Review of Clinical Immunology 17:11, pages 1211-1220.
Read now

Articles from other publishers (29)

Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian Schneeweiss, Marina Otten, Matthias Augustin & Benjamin Friedrich. (2023) The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany. Dermatology and Therapy 13:11, pages 2609-2620.
Crossref
Panagiotis Athanassiou, Lambros Athanassiou & Ifigenia Kostoglou-Athanassiou. 2023. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 557 565 .
Yu Meng, Furong Zeng, Huiyan Sun, Yayun Li, Xiang Chen & Guangtong Deng. (2022) Clinical characteristics and outcomes of patients with COVID‐19 and psoriasis. Journal of Medical Virology 94:12, pages 5850-5857.
Crossref
Janette Baloghová, Tomáš Kampe, Peter Kolarčik & Elena Hatalová. (2022) Vaccination, Risk Factors and Outcomes of COVID-19 Infection in Patients with Psoriasis—A Single Centre Real-Life Experience from Eastern Slovakia. Viruses 14:8, pages 1646.
Crossref
D. Koumaki, S.‐E. Krueger‐Krasagakis, M. Papadakis, A.C. Katoulis, I. Gkiaouraki, K. Zografaki, D. Mylonakis & K. Krasagakis. (2022) Psoriasis flare‐up after AZD1222 and BNT162b2 COVID‐19 mRNA vaccines: report of twelve cases from a single centre. Journal of the European Academy of Dermatology and Venereology 36:6.
Crossref
Amr Ehab El‐Qushayri, Mariam Abdelmageed Mahmoud, Samar Salman, Sameh Sarsik & Beatrice Nardone. (2022) Dupilumab therapy in atopic dermatitis is safe during COVID‐19 infection era: A systematic review and meta‐analysis of 1611 patients. Dermatologic Therapy 35:6.
Crossref
Anna Campanati, Federico Diotallevi, Emanuela Martina, Giulia Radi & Annamaria Offidani. (2022) Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. Journal of Clinical Medicine 11:9, pages 2422.
Crossref
Elham Behrangi, Afsaneh Sadeghzadeh‐Bazargan, Nastaran Salimi, Zoha Shaka, Mohammad Hosein Feyz Kazemi & Azadeh Goodarzi. (2022) Erythrodermic flare‐up of psoriasis with COVID‐19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID‐19 on each other along with the special challenges of the pandemic. Clinical Case Reports 10:4.
Crossref
Maria Esposito, Anna Campanati, Alessandro Giunta, Gianluca Calianno, Luca Bianchi, Federico Diotallevi, Anna Maria Offidani & Maria Concetta Fargnoli. (2022) Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic. Dermatology and Therapy 12:3, pages 671-681.
Crossref
Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Barbara Lari, Valentina Grossi, Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, Lavinia Quintarelli, Alice Verdelli, Francesca Li Gobbi, Emiliano Antiga & Marzia Caproni. (2022) Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?. Frontiers in Medicine 9.
Crossref
Y. Lytvyn, J.R. Georgakopoulos, A. Mufti, A.R. Devani, M.J. Gooderham, V. Jain, P. Lansang, R. Vender, V.H. Prajapati & J. Yeung. (2021) Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study. Journal of the European Academy of Dermatology and Venereology 36:2.
Crossref
K. Hansel, A. Zangrilli, L. Bianchi, K. Peris, A. Chiricozzi, A. Offidani, F. Diotallevi, M.C. Fargnoli, M. Esposito, P. Amerio, G. Gualdi, L. Bianchi & L. Stingeni. (2021) A 52‐week update of a multicentre real‐life experience on effectiveness and safety of risankizumab in psoriasis. Journal of the European Academy of Dermatology and Venereology 36:2.
Crossref
Zoe Apalla, Christina Fotiadou, Anastasia Emvalomati, Aikaterini Patsatsi, Myrto Trakatelli, Anastasia Trigoni, Athanassios Kyrgidis, Christina Trakatelli, Georgios Papazisis, Aimilios Lallas, Ourania Droggoula, Melpomeni‐Maria Giannakaki, Valentina Oflidou, Styliani Siskou, Maria Boziou, Kalliopi Karydi, Athena Daponte, Christina Kemanetzi, Fragkiski Tsatsou, Eirini Kyrmanidou & Elizabeth Lazaridou. (2021) The impact of COVID‐19 pandemic on psoriasis patients in northern Greece. Dermatologic Therapy 35:2.
Crossref
Maria Letizia Musumeci, Giuliana Caruso, Andrea Calogero Trecarichi & Giuseppe Micali. (2021) Safety of SARS‐CoV‐2 vaccines in psoriatic patients treated with biologics: A real life experience. Dermatologic Therapy 35:1.
Crossref
I. Gracia-Darder, J. Garcías-Ladaria, D. Ramos Rodríguez & J. Escalas Taberner. (2022) [Translated article] Biologic Therapy for Psoriasis During the COVID-19 Pandemic: A Case Series of Patients Treated in Hospital Universitario Son Espases. Actas Dermo-Sifiliográficas 113:1, pages T110-T112.
Crossref
I. Gracia-Darder, J. Garcías-Ladaria, D. Ramos Rodríguez & J. Escalas Taberner. (2022) Psoriasis en tratamiento biológico durante la pandemia COVID-19: serie de pacientes del Hospital Universitario Son Espases. Actas Dermo-Sifiliográficas 113:1, pages 110-112.
Crossref
Edward Hadeler, Julie Hong, Megan Mosca, Marwa Hakimi & Tina Bhutani. 2022. Biologic Therapy for Psoriasis. Biologic Therapy for Psoriasis 125 130 .
Huanhuan Zeng, Siyu Wang, Ling Chen & Zhu Shen. (2021) Biologics for Psoriasis During the COVID-19 Pandemic. Frontiers in Medicine 8.
Crossref
D. Thaçi, D. Jullien, A. Egeberg, J.M. Carrascosa, J.J. Wu, I. Pau‐Charles & P. Gisondi. (2021) Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate‐to‐severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. Journal of the European Academy of Dermatology and Venereology 35:11.
Crossref
Basak Yalici‐Armagan, Gulsun Hazan Tabak, Sibel Dogan‐Gunaydin, Duygu Gulseren, Neslihan Akdogan & Nilgun Atakan. (2021) Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. Journal of Cosmetic Dermatology 20:10, pages 3098-3102.
Crossref
I. Gracia-Darder, J. Garcías-Ladaria, D. Ramos Rodríguez & J. Escalas Taberner. (2021) WITHDRAWN: Biologic Therapy for Psoriasis During the COVID-19 Pandemic: A Case Series of Patients Treated in Hospital Universitario Son Espases. Actas Dermo-Sifiliográficas (English Edition).
Crossref
Andrea Conti, Giovanni Damiani, Roberta Ruggeri, Giulia Odorici, Francesca Farnetani, Paolo Daniele Maria Pigatto & Giovanni Pellacani. (2021) Switching infliximab in psoriatic patients during COVID ‐19 pandemics: A real‐life retrospective study comparing intra‐versus interclass switching strategies . Dermatologic Therapy 34:5.
Crossref
Khalaf Kridin, Yochai Schonmann, Dana Tzur Bitan, Giovanni Damiani, Alon Peretz, Orly Weinstein & Arnon D. Cohen. (2021) Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study. American Journal of Clinical Dermatology 22:5, pages 709-718.
Crossref
Magdalena Mroz, Szymon Mućka, Martyna Miodońska, Dominika Ziolkowska, Ewa Hadas & Andrzej Bożek. (2021) Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs. Medicina 57:9, pages 881.
Crossref
Martyna Miodońska, Agnieszka Bogacz, Magdalena Mróz, Szymon Mućka & Andrzej Bożek. (2021) The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients. Medicina 57:6, pages 521.
Crossref
Luca STINGENI, Leonardo BIANCHI, Ketty PERIS, Gabriella FABBROCINI, Giuseppe MICALI, Piergiacomo CALZAVARA-PINTON, Marta TRAMONTANA & Katharina HANSEL. (2021) SARS-CoV-2 vaccines and biological treatments: dermatological perspectives. Italian Journal of Dermatology and Venereology 156:2.
Crossref
Joel M. Gelfand, April W. Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo ReIIIIII, George Martin, Joseph F. Merola, Jose U. Scher, Sergio Schwartzman, James R. Treat, Abby S. Van Voorhees, Christoph T. Ellebrecht, Justine Fenner, Anthony Ocon, Maha N. Syed, Erica J. Weinstein, George Gondo, Sue Heydon, Samantha Koons & Christopher T. Ritchlin. (2021) National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. Journal of the American Academy of Dermatology 84:5, pages 1254-1268.
Crossref
Semih Güder & Hüsna Güder. (2021) The course of COVID‐19 infection and prolonged sneezing and nasal congestion in a patient using ixekizumab. Dermatologic Therapy 34:2.
Crossref
Thomas Graier, Nicole Golob-Schwarzl, Wolfgang Weger, Theresa Benezeder, Clemens Painsi, Wolfgang Salmhofer & Peter Wolf. (2021) Furin Expression in Patients With Psoriasis—A Patient Cohort Endangered to SARS-COV2?. Frontiers in Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.